Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


01 mayo 2015

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Radiofrequency Ablation of Lung Metastases from Adenoid Cystic Carcinoma of the Head and Neck: Retrospective Evaluation of Nine Patients

Toshihiro Iguchi, MD , Takao Hiraki, MD , Hideo Gobara, MD , Hiroyasu Fujiwara, MD , Yusuke Matsui, MD , Shinichi Toyooka, MD , Kazunori Nishizaki, MD , Susumu Kanazawa, MD

Purpose: To retrospectively evaluate the outcomes of radiofrequency (RF) ablation of lung metastases from head and neck adenoid cystic carcinoma (ACC)

01 mayo 2015

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Percutaneous Transhepatic Cholangiography and Intraductal Radiofrequency Ablation Combined with Biliary Stent Placement for Malignant Biliary Obstruction

Teng-Fei Li, MD , Guo-Hao Huang, MMM , Zhen Li, MD , Chang-Fu Hao, MD , Jian-Zhuang Ren , Xu-Hua Duan, MD , Kai Zhang, MMM , Chen Chen, MD , Xin-Wei Han, MD , De-Chao Jiao, MD , Meng-Fan Zhang, MD , Yan-Li Wang, MD

Purpose: To determine the safety and feasibility of percutaneous transhepatic cholangiography (PTC) and intraductal radiofrequency (RF) ablation combined with biliary stent placement for malignant biliary obstruction.

01 mayo 2015

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Gene Expression in Hepatocellular Carcinoma: Pilot Study of Potential Transarterial Chemoembolization Response Biomarkers

Ron C. Gaba, MD , John V. Groth, MD , Ahmad Parvinian, MD , Grace Guzman, MD , Leigh C. Casadaban, BS

Purpose: To perform a feasibility study to explore the relationship between hepatocellular carcinoma genetics and transarterial chemoembolization treatment response to identify potential biomarkers associated with enhanced treatment efficacy.

01 junio 2015

JOURNAL OF HEPATOLOGY. Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma

Beom Kyung Kim , Seung Up Kim , Kyung Ah Kim , Yong Eun Chung , Myeong-Jin Kim , Mi-Suk Park , Jun Yong Park , Do Young Kim , Sang Hoon Ahn , Man Deuk Kim , Sung Il Park , Jong Yoon Won , Do Yun Lee , Kwang-Hyub Han

Backgrounds & Aims: The aim of this study is to evaluate the prognostic significances of not only the initial and the best response during repeated transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC), but if eligible, also the time point of achieving treatment responses.

01 mayo 2015

JOURNAL OF HEPATOLOGY. Optimal methods for measuring eligibility for liver transplant in hepatocellular carcinoma patients undergoing transarterial chemoembolization

Hyung-Don Kim , Ju Hyun Shim , Gi-Ae Kim , Yong Moon Shin , Eunsil Yu , Sung-Gyu Lee , Danbi Lee , Kang Mo Kim , Young-Suk Lim , Han Chu Lee , Young-Hwa Chung , Yung Sang Lee

Background & Aims: We investigated the optimal radiologic method for measuring hepatocellular carcinoma (HCC) treated by transarterial chemoembolization (TACE) in order to assess suitability for liver transplantation (LT).

01 abril 2015

EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. Emergency Treatment of Haemorrhaging Coeliac or Mesenteric Artery Aneurysms and Pseudoaneurysms in the Era of Endovascular Management

K.J. Roberts , N. McCulloch , C. Forde , B. Mahon , K. Mangat , S.P. Olliff , R.G. Jones

Objectives: Patients requiring emergency treatment of visceral artery aneurysms (VAAs) can be treated by endovascular or surgical techniques. Outcomes after failed attempts at endovascular control are unclear as is the present role of surgery. This study reviewed treatment and outcomes of a contemporary cohort of patients with symptomatic VAAs at a tertiary referral centre.

01 abril 2015

EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. Venous In-stent Thrombosis Treated by Ultrasound Accelerated Catheter Directed Thrombolysis

R.H.W. Strijkers , M.A.F. de Wolf , C.W.K.P. Arnoldussen , M.J.M. Timbergen , R. de Graaf , A.J. Ten Cate-Hoek , C.H.A. Wittens

Objective/Background: Stent placement in the venous system is an increasingly used treatment modality in chronic venous obstruction and as additional treatment after thrombolytic therapy in ilio-femoral deep vein thrombosis (DVT). Experience in treating in-stent thrombosis with ultrasound accelerated catheter directed thrombolysis (UACDT) is reported.

01 mayo 2015

CATHETERIZATION AND CARDIOVASCULAR INTERVENTION. Acute, subacute, and long-term evaluation of a novel endovascular occlusion system in a large animal model

Anthony Venbrux MD, Philippe Gailloud MD, Martin G. Radvany MD, Leon Rudakov PhD, Maximilian Y. Emmert MD, Andre Plass MD, Serge D. Rousselle DVM and Armando Tellez MD5,

Objectives: Endovascular occlusion of blood vessels represents a key component of interventional therapy. While coils are most commonly used, vessel occlusion is generally not achieved immediately and may necessitate a large number of devices. It has been suggested that endovascular plugs may overcome these limitations; however, immediate and durable occlusion remains a challenge with plugs as well. This study evaluates a newly designed endovascular occlusion system (EOS)

01 junio 2015

HPB. Tumour growth after portal vein embolization with pre-procedural chemotherapy for colorectal liver metastases

Lidewij Spelt, Ernesto Sparrelid, Bengt Isaksson, Roland G. Andersson and Christian Sturesson

Background: For resection of colorectal cancer (CRC) liver metastases, pre-operative portal vein embolization (PVE) is used to increase the size of the future liver remnant (FLR) prior to advanced liver resection when indicated. PVE is speculated to cause tumour progression, but only a limited number of studies have analysed tumour growth after PVE in the context of pre-procedural chemotherapy, which was the aim of this retrospective study.

01 mayo 2015

HPB. Results of laparoscopic radiofrequency ablation for HCC. Could the location of the tumour influence a complete response to treatment? A single European centre experience

Sofía de la Serna, Ramón Vilana, Santiago Sánchez-Cabús, David Calatayud, Joana Ferrer, Victor Molina, Constantino Fondevila, Jordi Bruix, Josep Fuster and Juan-Carlos García-Valdecasas

Introduction: In selected patients, radiofrequency ablation (RFA) is a well-established treatment for hepatocellular carcinoma (HCC). However, subcapsular or lesions close to adjacent viscera preclude a percutaneous approach. In this setting laparoscopic-RFA (LRFA) is a potential alternative. The aim of this study was to analyse the safety and feasibility of LRFA in patients with HCC.

01 abril 2015

HPB. Percutaneous cholecystostomy is an effective treatment option for acute calculous cholecystitis: a 10-year experience

Torben Horn, Sara D. Christensen, Jakob Kirkegård, Lars P. Larsen, Anders R. Knudsen and Frank V. Mortensen

Background: Percutaneous cholecystostomy (PC) can be used to treat patients with acute calculous cholecystitis (ACC) who are considered to be unfit for surgery. However, this procedure has been insufficiently investigated. This paper presents the results of a 10-year experience with this treatment modality.

01 marzo 2015

HPB. Radiofrequency ablation versus transarterial chemoembolization for unresectable solitary hepatocellular carcinomas sized 5–8 cm

Wing Chiu Dai, Tan To Cheung, Kenneth S. H. Chok, Albert C. Y. Chan, William W. Sharr, Simon H. Y. Tsang, Wai Key Yuen, See Ching Chan, Sheung Tat Fan, Chung Mau Lo andRonnie T. P. Poon

Objectives: This retrospective review was conducted to compare the efficacy of radiofrequency ablation (RFA) with that of transarterial chemoembolization (TACE) in treating large (5–8 cm) unresectable solitary hepatocellular carcinomas (HCCs).

01 febrero 2015

HPB. Adjuvant stereotactic body radiotherapy following transarterial chemoembolization in patients with non-resectable hepatocellular carcinoma tumours of ≥3 cm

Rojymon Jacob, Falynn Turley, David T. Redden, Souheil Saddekni, Ahmed K. A. Aal, Kimberly Keene, Eddy Yang, Jessica Zarzour, David Bolus, J. Kevin Smith, Stephen Gray, Jared White, Devin E. Eckhoff and Derek A. DuBay

Objectives: The optimal locoregional treatment for non-resectable hepatocellular carcinoma (HCC) of ≥3 cm in diameter is unclear. Transarterial chemoembolization (TACE) is the initial intervention most commonly performed, but it rarely eradicates HCC. The purpose of this study was to measure survival in HCC patients treated with adjuvant stereotactic body radiotherapy (SBRT) following TACE.

01 mayo 2015

HPB. Multimodal treatment of unresectable hepatocellular carcinoma to achieve complete response results in improved survival

Pippa H. Newell, YingXing Wu, Helena Hoen, Richa Uppal, John Tyler Thiesing6, Kevin Sasadeusz6, Maria A. Cassera, Ronald F. Wolf,, Paul Hansen and Chet W Hammill

Introduction: With technological advances, questions arise regarding how to best fit newer treatment modalities, such as transarterial therapies, into the treatment algorithm for patients with hepatocellular carcinoma (HCC).

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.